Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial

Journal of Vascular Surgery(2024)10.1016/j.jvs.2024.04.025Source: DataRank Database

Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial is a research paper published in Journal of Vascular Surgery (2024). On theSindex it has a DataRank of 0.165. It has been cited 2 times, with 2 citing works in its 1-hop citation network.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access2 citations · 2 citing works in its network

Free full text

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02060630

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.29)OA: bronzeTopics (51)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

From 0 citing papers with measurable signal

This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.

Learn more about DataRank methodology →

Authors (9)

Matthew T. Menard ORCID,Kenneth Rosenfield ORCID,Michael S. Conte ORCID,Richard J. Powell,Naomi Hamburg ORCID

Live enrichment

PubMed:38626847 OpenAlex:https://openalex.org/W4394858712

NHLBI NIH HHS

Grant: U01 HL107352

NHLBI NIH HHS

Grant: U01 HL107407

NHLBI NIH HHS

Grant: U01 HL115662

NHLBI

FWCI

1.29

Citation Percentile

0.8%

Citation Trend

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jvascsurg.org/article/S074152142400987X/pdf

publisherhttp://www.jvascsurg.org/article/S074152142400987X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S074152142400987X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S074152142400987X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jvs.2024.04.025

Fields of Study

Peripheral Artery Disease ManagementCerebrovascular and Carotid Artery DiseasesCoronary Interventions and DiagnosticsAgedFemaleHumansMaleMiddle AgedChronic Limb-Threatening IschemiaEndovascular ProceduresProspective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeVascular GraftingPostoperative ComplicationsHeart Diseases

MeSH Terms

Chronic Limb-Threatening IschemiaAgedFemaleHeart DiseasesHumansIschemiaMaleMiddle AgedPostoperative ComplicationsProspective StudiesRisk FactorsTime FactorsTreatment OutcomeRisk AssessmentEndovascular ProceduresVascular GraftingPeripheral Arterial Disease

Keywords

MedicineRevascularizationCardiac surgeryAdverse effectRandomized controlled trialVascular surgeryClinical trialSurgeryBypass surgeryInternal medicineCardiologyMyocardial infarctionArteryEndovascularBypasscardiovascular

Sustainable Development Goals

SDG 0: Good health and well-being